Jiangling Wan
Impact in
- Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Drug Discovery top 2%
Papers in
-
- Drug Solubulity and Delivery Systems 9
- Advancements in Transdermal Drug Delivery 5
- Advanced Drug Delivery Systems 3
- Biomaterials 14
- Nanoparticle-Based Drug Delivery 12
- Electrospun Nanofibers in Biomedical Applications 2
- Co-authors
- Xiangliang Yang (35 shared papers)Huibi Xu (17 shared papers)Huabing Chen (6 shared papers)Tao Yi (3 shared papers)Zifu Li (8 shared papers)Dongsheng Mou (4 shared papers)Jiankun Guan (2 shared papers)Wei Liu (5 shared papers)
- Journals
- RSC Advances (4 papers)Nanotechnology (3 papers)Chemical Engineering Journal (3 papers)Biomaterials (2 papers)Nanoscale (2 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Jiangling Wan
46 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 90
- Pharmaceutical Science 746
- Drug Discovery 23
- Biomaterials 595
- Molecular Medicine 89
- Biomedical Engineering 396
Countries citing papers authored by Jiangling Wan
This map shows the geographic impact of Jiangling Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangling Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangling Wan more than expected).
Fields of papers citing papers by Jiangling Wan
This network shows the impact of papers produced by Jiangling Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangling Wan. The network helps show where Jiangling Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiangling Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 187 | |
| 2 | 2009 | 172 | |
| 3 | 2013 | 146 | |
| 4 | 2011 | 118 | |
| 5 | 2009 | 114 | |
| 6 | 2019 | 109 | |
| 7 | 2020 | 99 | |
| 8 | 2019 | 86 | |
| 9 | 2017 | 83 | |
| 10 | 2018 | 79 | |
| 11 | 2014 | 76 | |
| 12 | 2012 | 73 | |
| 13 | 2013 | 60 | |
| 14 | 2012 | 58 | |
| 15 | 2011 | 55 | |
| 16 | 2018 | 52 | |
| 17 | 2024 | 50 | |
| 18 | 2008 | 45 | |
| 19 | 2021 | 44 | |
| 20 | 2022 | 34 |
About Jiangling Wan
Jiangling Wan is a scholar working on Pharmaceutical Science, Biomaterials, Biomedical Engineering, Hepatology and Analytical Chemistry, having authored 47 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Drug Solubulity and Delivery Systems (9 papers), Nanoplatforms for cancer theranostics (5 papers), Advancements in Transdermal Drug Delivery (5 papers), Advanced Drug Delivery Systems (3 papers), Protein Hydrolysis and Bioactive Peptides (3 papers), Electrospun Nanofibers in Biomedical Applications (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Pharmaceutical Science (746 citations), Drug Discovery (23 citations), Biomaterials (595 citations), Molecular Medicine (89 citations) and Biomedical Engineering (396 citations). Jiangling Wan has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Xiangliang Yang, Huibi Xu, Huabing Chen, Tao Yi, Zifu Li, Dongsheng Mou, Jiankun Guan, Wei Liu, Chen Xiao and Yuxiang Tang. Their work appears in journals such as RSC Advances, Nanotechnology, Chemical Engineering Journal, Biomaterials and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.